Does fasting during Ramadan trigger non-adherence to oral hormonal therapy in breast cancer patients?

Journal of the Egyptian National Cancer Institute

Volumn 24, Issue 3, 2012, Pages 133-137

  Zeeneldin, Ahmed Abdelmabood ^a   Gaber, Ayman Abdelsamee ^a   Taha, Fatma Mohamed ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Breast cancer; Egypt; Fasting; Hormonal therapy; Ramadan

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; AROMAZIN; EXEMESTANE; LETROZOLE; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER HORMONE THERAPY; DIET RESTRICTION; EGYPT; EPIGASTRIC PAIN; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MOSLEM; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERFORMANCE; POSTMENOPAUSE; RELIGION; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; FASTING; FEMALE; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; RELIGION AND MEDICINE; TAMOXIFEN;

EID: 84865425570     PISSN: 11100362     EISSN: 16879996     Source Type: Journal    
DOI: 10.1016/j.jnci.2012.06.003     Document Type: Article

References (14)

1. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5. Version 2.0. Lyon: IARC Press; 2004.
2. The Gharbiah Population-based Cancer Registry (GPCR): Cancer in Egypt, Gharbiah. <>; 2007 [accessed 05.10.10]. http://www.emro.who.int/ncd/pdf/cancer_registry_Egypt.pdf.
3. Early Breast Cancer Trialists' Collaborative Group (EBCTG). Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998;351:1451-67.
4. Chlebowski R.T., Geller M.L. Adherence to endocrine therapy for breast cancer. Oncology 2006, 71(1-2):1-9.
5. Partridge A.H., Wang P.S., Winer E.P., Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003, 21:602-606.
6. McDonald H., Garg A., Haynes R. Interventions to enhance patient adherence to medication prescriptions. J Am Med Assoc 2002, 288(22):2868-2879.
7. Atkins L., Fallowfield L. Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer 2006, 42(14):2271-2276.
8. Elwyn G., Edwards A., Britten N. 'Doing prescribing': how doctors can be more effective. Brit Med J 2003, 327:864-867.
9. Ziller V., Kalder M., Albert U.S., Holzhauer W., Ziller M., Wagner U., et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 2009, 20(3):431-436.
10. Ruddy K.J., Partridge A.H. Adherence with adjuvant hormonal therapy for breast cancer. Ann Oncol 2009, 20(3):401-402.
11. Integrated Regional Information Networks, Egypt: Illiteracy still rife among rural women in 2005. <>; 2006 [accessed 25.11.10]. http://www.irinnews.org/Report.aspx?ReportId=26179.
12. Partridge A.H. Non-adherence to endocrine therapy for breast cancer. Ann Oncol 2006, 17(2):183-184.
13. Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005, 365(9453):60-62.
14. Coombes R.C., Hall E., Gibson L.J., Paridaens R., Jassem J., Delozier T., et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004, 350(11):1081-1092.